BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 37336982)

  • 1. Alternative splicing in neurodegenerative disease and the promise of RNA therapies.
    Nikom D; Zheng S
    Nat Rev Neurosci; 2023 Aug; 24(8):457-473. PubMed ID: 37336982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures.
    Reddy K; Zamiri B; Stanley SYR; Macgregor RB; Pearson CE
    J Biol Chem; 2013 Apr; 288(14):9860-9866. PubMed ID: 23423380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis.
    Katzeff JS; Bright F; Phan K; Kril JJ; Ittner LM; Kassiou M; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS
    Brain; 2022 Jun; 145(5):1598-1609. PubMed ID: 35202463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau Isoforms: Gaining Insight into
    Corsi A; Bombieri C; Valenti MT; Romanelli MG
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases.
    Kinoshita C; Kubota N; Aoyama K
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?
    Mizielinska S; Isaacs AM
    Curr Opin Neurol; 2014 Oct; 27(5):515-23. PubMed ID: 25188012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau mis-splicing in the pathogenesis of neurodegenerative disorders.
    Park SA; Ahn SI; Gallo JM
    BMB Rep; 2016 Aug; 49(8):405-13. PubMed ID: 27222125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies.
    Li D; McIntosh CS; Mastaglia FL; Wilton SD; Aung-Htut MT
    Transl Neurodegener; 2021 May; 10(1):16. PubMed ID: 34016162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.
    Benatar M; Wuu J; McHutchison C; Postuma RB; Boeve BF; Petersen R; Ross CA; Rosen H; Arias JJ; Fradette S; McDermott MP; Shefner J; Stanislaw C; Abrahams S; Cosentino S; Andersen PM; Finkel RS; Granit V; Grignon AL; Rohrer JD; McMillan CT; Grossman M; Al-Chalabi A; Turner MR;
    Brain; 2022 Mar; 145(1):27-44. PubMed ID: 34677606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding age-related pathologic changes in TDP-43 functions and the consequence on RNA splicing and signalling in health and disease.
    Cheng F; Chapman T; Zhang S; Morsch M; Chung R; Lee A; Rayner SL
    Ageing Res Rev; 2024 Apr; 96():102246. PubMed ID: 38401571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic inclusions UNCover losses driving neurodegeneration.
    Bademosi AT; Walker AK
    Trends Genet; 2022 Sep; 38(9):889-891. PubMed ID: 35773026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA toxicity in non-coding repeat expansion disorders.
    Swinnen B; Robberecht W; Van Den Bosch L
    EMBO J; 2020 Jan; 39(1):e101112. PubMed ID: 31721251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing isoforms in health and disease.
    Kim HK; Pham MHC; Ko KS; Rhee BD; Han J
    Pflugers Arch; 2018 Jul; 470(7):995-1016. PubMed ID: 29536164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unstable repeat expansions in neurodegenerative diseases: nucleocytoplasmic transport emerges on the scene.
    Loureiro JR; Oliveira CL; Silveira I
    Neurobiol Aging; 2016 Mar; 39():174-83. PubMed ID: 26923414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of FET proteins in neurodegenerative disorders.
    Svetoni F; Frisone P; Paronetto MP
    RNA Biol; 2016 Nov; 13(11):1089-1102. PubMed ID: 27415968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau alternative splicing and frontotemporal dementia.
    Kar A; Kuo D; He R; Zhou J; Wu JY
    Alzheimer Dis Assoc Disord; 2005; 19 Suppl 1(Suppl 1):S29-36. PubMed ID: 16317255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients.
    Yin S; Lopez-Gonzalez R; Kunz RC; Gangopadhyay J; Borufka C; Gygi SP; Gao FB; Reed R
    Cell Rep; 2017 Jun; 19(11):2244-2256. PubMed ID: 28614712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
    Shang Y; Huang EJ
    Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation of the poly(GR) frame in C9ORF72-ALS/FTD is regulated by cis-elements involved in alternative splicing.
    Lampasona A; Almeida S; Gao FB
    Neurobiol Aging; 2021 Sep; 105():327-332. PubMed ID: 34157654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.